Approval · Notice of Compliance 37202 · 2026
SPEVIGO: Notice of Compliance 37202
Issued March 26, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37202
- Date
- March 26, 2026
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- SPESOLIMAB 60 MG per ML
- SPESOLIMAB 150 MG per ML